U.S. Department of Health & Human Services
National Institutes of Health
NCATS
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
CDX-1135
2RF4H67MOG
Investigational
General
Names
4
Classification
2
Identifiers
1
Related Substances
1
CDX-1135
2RF4H67MOG
Investigational
General
Approval Year
Unknown
139,594
Names
4
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
CDX-1135
Code
English
SOLUBLE COMPLEMENT RECEPTOR TYPE 1
Common Name
English
HUMAN RECOMBINANT SOLUBLE COMPLEMENT RECEPTOR TYPE 1
Common Name
English
YM-203
Code
English
Showing 1 to 4 of 4 entries
Previous
1
Next
Classification
2
Show
5
20
100
All
entries
Classification Tree
Code System
Code
Classification Tree
Code System
Code
Designated
ORPHAN DRUG
Designated
Prevention of post-cardiopulmonary bypass syndrome in children undergoing cardiopulmonary bypass.
FDA ORPHAN DRUG
131899
Designated
ORPHAN DRUG
Designated
Prevention or reduction of adult respiratory distress syndrome.
FDA ORPHAN DRUG
82894
Showing 1 to 2 of 2 entries
Previous
1
Next
Identifiers
1
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
FDA UNII
2RF4H67MOG
PRIMARY
Showing 1 to 1 of 1 entries
Previous
1
Next
Related Substances
1
ACTIVE MOIETY
2RF4H67MOG
CDX-1135